RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

NCT01490086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: RP5063
DRUG: placebo
DRUG: aripiprazole

Sponsor

Reviva Pharmaceuticals